Saikosaponin B2

Saikosaponin B2 is an active component from Bupleurum chinensis root, acts as an entry inhibitor against HCV infection[1]. Anti-cancer activity[2].

Product Specifications

CAS Number

[58316-41-9]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

HCV

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/saikosaponin-b2.html

Purity

99.9

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC[C@@]1(C)[C@]2([H])CC[C@@]3(C)[C@]4(C)C[C@@H](O)[C@@]5(CO)CCC(C)(C)CC5=C4C=C[C@]3([H])[C@@]2(C)CC[C@@H]1O[C@]6([H])O[C@H](C)[C@H](O)[C@H](O[C@]7([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O

Molecular Formula

C42H68O13

Molecular Weight

780.98

Precautions

H302, H315, H319, H335

References & Citations

[1]Lin LT, et al. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J Hepatol. 2015 Mar;62 (3) :541-8.|[2]Ma Q, et al. Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration. Mol Med Rep. 2019 Aug;20 (2) :1943-1951.